Status:
COMPLETED
Sitosterolemia Extension Study (0653-003)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Lipid Metabolism, Inborn Errors
Heart Disease
Eligibility:
All Genders
10+ years
Phase:
PHASE3
Brief Summary
This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability ...
Detailed Description
The duration of treatment is 52 weeks.
Eligibility Criteria
Inclusion
- Patients with elevated sitosterol levels while taking current medication
Exclusion
- Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study.
Key Trial Info
Start Date :
February 12 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2004
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00092807
Start Date
February 12 2001
End Date
November 30 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.